Cargando…
A dark side to NS1 antibodies?
The NS1 protein of flaviviruses is taking center stage. Recent work has made it an attractive target for development of vaccines and immunotherapeutics. Cavazzoni and colleagues (2021. J. Exp. Med. https://doi.org/10.1084/jem.20210580) now reveal a dark side to NS1, linking it to the development of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Rockefeller University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321876/ https://www.ncbi.nlm.nih.gov/pubmed/34319348 http://dx.doi.org/10.1084/jem.20211348 |